Figure 4b,c presents the side views of the patterned structures after completion of the imprint and withdrawing stages, respectively.
Following completion of the treatment phase, subjects were withdrawn from study medication while continuing their SRIs.
The main source of low yields is believed to be due to the deactivation of the ring system to the second ring closing step after the completion of the first due to the electron withdrawing effect of the isatin.
After completion of the imprint stage, in the following withdrawing stage, the force first decreases precipitously, followed by a minor increase.
Proposals for which the application was withdrawn before completion of the review were excluded.
> -wrap-foot> Twelve additional participants (nine migraineurs, three HCs) withdrew before completion of the study.
One male patient was non-compliant with the study protocol and susbsequently withdrew before completion of the study.
Other than the 6 participants who withdrew before completion of the trial, there was no further loss to follow up.
Of the 16 (37%) patients who withdrew before completion of the 12-week study period, occurrence of an AE was cited as the primary cause of discontinuation.
Patients who withdrew before completion of the study treatment or who were declared ineligible (n=9) were excluded from the primary analyses of toxicity and second look.
